Cholesterol therapy
Statins are the main class of medication used to reduce high cholesterol levels—primarily of low-density lipoprotein (LDL) cholesterol—which are a risk factor for ischaemic stroke.
The most recent National Stroke Audit of Rehabilitation Services showed that around 88% of eligible patients with ischaemic stroke were on lipid-lowering therapy on discharge from hospital. However. Australian GP registry records indicate that in the community this rate fell to 65%.
Lifestyle change strategies involving dietary modification have been shown to lower cholesterol levels in those with cardiovascular risks and should be used as an alternative or in addition to pharmacotherapy.
For current research and evidence-based recommendations see our Clinical Guidelines.
Stroke Foundation respectfully acknowledges the Traditional Owners and Custodians of Country throughout Australia, whose sovereignty was never ceded, and acknowledges their continuing connection to land, water, sky and community. We pay our respect to the peoples, cultures, and Elders past, present and emerging, for they hold the memories, culture and hope of their peoples.
© 2025 Stroke Foundation ABN 42 006 173 379 - All donations $2 and over are tax deductible